Cargando…

Development and Validation of a Pyroptosis-Related Signature for Predicting Prognosis in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) has emerged as a primary health problem and threat to global mortality, especially in China. Since pyroptosis as a new field for HCC prognosis is not well studied, it is important to open a specific prognostic model. In this study, consensus clustering method for 42 py...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Jianfeng, He, Xiaobo, Luo, Wei, Zhou, Weiguo, Chen, Rui, Cao, Guodong, Chen, Bo, Xiong, Maoming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818951/
https://www.ncbi.nlm.nih.gov/pubmed/35140750
http://dx.doi.org/10.3389/fgene.2022.801419
_version_ 1784645946940850176
author Ding, Jianfeng
He, Xiaobo
Luo, Wei
Zhou, Weiguo
Chen, Rui
Cao, Guodong
Chen, Bo
Xiong, Maoming
author_facet Ding, Jianfeng
He, Xiaobo
Luo, Wei
Zhou, Weiguo
Chen, Rui
Cao, Guodong
Chen, Bo
Xiong, Maoming
author_sort Ding, Jianfeng
collection PubMed
description Hepatocellular carcinoma (HCC) has emerged as a primary health problem and threat to global mortality, especially in China. Since pyroptosis as a new field for HCC prognosis is not well studied, it is important to open a specific prognostic model. In this study, consensus clustering method for 42 pyroptosis-related genes to classify 374 HCC patients in the TCGA database. After cox regression analysis of the differentially expressed genes between the two clusters, LASSO-Cox analysis was then performed to construct a pyroptosis-related prognostic model with 11 genes including MMP1, KPNA2, LPCAT1, NEIL3, CDCA8, SLC2A1, PSRC1, CBX2, HAVCR1, G6PD, MEX3A. The ICGC dataset was served as the validation cohort. Patients in the high-risk group had significantly lower overall survival (OS) rates than those in the low-risk group (p < 0.05). COX regression analysis showed that our model could be used as an independent prognostic factor to predict prognosis of patients and was significantly correlated with clinicopathological characteristics. Nomogram showing the stability of the model predicting the 1, 3, 5 year survival probability of patients. In addition, based on the risk model, ssGSEA analysis revealed significant differences in the level of immune cell infiltration and activation of immune-related functional pathways between high and low-risk groups, and patients with the high-risk score may benefit more from treatment with immune checkpoint inhibitors. Furthermore, patients in the high-risk group were more tend to develop chemoresistance. Overall, we identified a novel pyroptosis-related risk signature for prognosis prediction in HCC patients and revealed the overall immune response intensity of the tumor microenvironment. All these findings make the pyroptosis signature shed light upon a latent therapeutic strategy aimed at the treatment and prevention of cancers.
format Online
Article
Text
id pubmed-8818951
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88189512022-02-08 Development and Validation of a Pyroptosis-Related Signature for Predicting Prognosis in Hepatocellular Carcinoma Ding, Jianfeng He, Xiaobo Luo, Wei Zhou, Weiguo Chen, Rui Cao, Guodong Chen, Bo Xiong, Maoming Front Genet Genetics Hepatocellular carcinoma (HCC) has emerged as a primary health problem and threat to global mortality, especially in China. Since pyroptosis as a new field for HCC prognosis is not well studied, it is important to open a specific prognostic model. In this study, consensus clustering method for 42 pyroptosis-related genes to classify 374 HCC patients in the TCGA database. After cox regression analysis of the differentially expressed genes between the two clusters, LASSO-Cox analysis was then performed to construct a pyroptosis-related prognostic model with 11 genes including MMP1, KPNA2, LPCAT1, NEIL3, CDCA8, SLC2A1, PSRC1, CBX2, HAVCR1, G6PD, MEX3A. The ICGC dataset was served as the validation cohort. Patients in the high-risk group had significantly lower overall survival (OS) rates than those in the low-risk group (p < 0.05). COX regression analysis showed that our model could be used as an independent prognostic factor to predict prognosis of patients and was significantly correlated with clinicopathological characteristics. Nomogram showing the stability of the model predicting the 1, 3, 5 year survival probability of patients. In addition, based on the risk model, ssGSEA analysis revealed significant differences in the level of immune cell infiltration and activation of immune-related functional pathways between high and low-risk groups, and patients with the high-risk score may benefit more from treatment with immune checkpoint inhibitors. Furthermore, patients in the high-risk group were more tend to develop chemoresistance. Overall, we identified a novel pyroptosis-related risk signature for prognosis prediction in HCC patients and revealed the overall immune response intensity of the tumor microenvironment. All these findings make the pyroptosis signature shed light upon a latent therapeutic strategy aimed at the treatment and prevention of cancers. Frontiers Media S.A. 2022-01-24 /pmc/articles/PMC8818951/ /pubmed/35140750 http://dx.doi.org/10.3389/fgene.2022.801419 Text en Copyright © 2022 Ding, He, Luo, Zhou, Chen, Cao, Chen and Xiong. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Genetics
Ding, Jianfeng
He, Xiaobo
Luo, Wei
Zhou, Weiguo
Chen, Rui
Cao, Guodong
Chen, Bo
Xiong, Maoming
Development and Validation of a Pyroptosis-Related Signature for Predicting Prognosis in Hepatocellular Carcinoma
title Development and Validation of a Pyroptosis-Related Signature for Predicting Prognosis in Hepatocellular Carcinoma
title_full Development and Validation of a Pyroptosis-Related Signature for Predicting Prognosis in Hepatocellular Carcinoma
title_fullStr Development and Validation of a Pyroptosis-Related Signature for Predicting Prognosis in Hepatocellular Carcinoma
title_full_unstemmed Development and Validation of a Pyroptosis-Related Signature for Predicting Prognosis in Hepatocellular Carcinoma
title_short Development and Validation of a Pyroptosis-Related Signature for Predicting Prognosis in Hepatocellular Carcinoma
title_sort development and validation of a pyroptosis-related signature for predicting prognosis in hepatocellular carcinoma
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818951/
https://www.ncbi.nlm.nih.gov/pubmed/35140750
http://dx.doi.org/10.3389/fgene.2022.801419
work_keys_str_mv AT dingjianfeng developmentandvalidationofapyroptosisrelatedsignatureforpredictingprognosisinhepatocellularcarcinoma
AT hexiaobo developmentandvalidationofapyroptosisrelatedsignatureforpredictingprognosisinhepatocellularcarcinoma
AT luowei developmentandvalidationofapyroptosisrelatedsignatureforpredictingprognosisinhepatocellularcarcinoma
AT zhouweiguo developmentandvalidationofapyroptosisrelatedsignatureforpredictingprognosisinhepatocellularcarcinoma
AT chenrui developmentandvalidationofapyroptosisrelatedsignatureforpredictingprognosisinhepatocellularcarcinoma
AT caoguodong developmentandvalidationofapyroptosisrelatedsignatureforpredictingprognosisinhepatocellularcarcinoma
AT chenbo developmentandvalidationofapyroptosisrelatedsignatureforpredictingprognosisinhepatocellularcarcinoma
AT xiongmaoming developmentandvalidationofapyroptosisrelatedsignatureforpredictingprognosisinhepatocellularcarcinoma